Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Cardio Diagnostics And 2 Other Penny Stocks Insiders Are Buying

Published 11/09/2023, 14:10
Updated 11/09/2023, 15:40
© Reuters.  Cardio Diagnostics And 2 Other Penny Stocks Insiders Are Buying

Benzinga - by Lisa Levin, Benzinga Editor.

The Dow Jones closed higher by around 75 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Rapid Micro Biosystems

  • The Trade: Rapid Micro Biosystems, Inc. (NASDAQ: RPID) CFO Sean M Wirtjes acquired a total of 10,000 shares an average price of $0.99. To acquire these shares, it cost around $9,894.
  • What’s Happening: Rapid Micro Biosystems posted upbeat second-quarter results.
  • What Rapid Micro Biosystems Does: Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables.
Cardio Diagnostics
  • The Trade: Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) Chief Technology Officer Timur Dogan acquired a total of 18,251 shares at an average price of $0.55. The insider spent around $9,965.
  • What’s Happening: Cardio Diagnostics partnered with Ascension Borgess Hospital's Heart Attack Prevention Clinic on coronary artery disease study.
  • What Cardio Diagnostics Does: Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise.
Altisource Portfolio Solutions
  • The Trade: Altisource Portfolio Solutions S.A. (NASDAQ: ASPS) Chairman and CEO William Shepro acquired a total of 41,667 shares at an average price of $3.60. To acquire these shares, it cost around $150,001. The company’s CFO and Director also purchased the company’s shares.
  • What’s Happening: Altisource Portfolio Solutions S priced its underwritten public offering of 4.8 million shares at a price to the public of $3.60 per share.
  • What Altisource Portfolio Solutions Does: Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Check This Out: Top 5 Tech Stocks That May Crash In September

Don’t forget to check out our premarket coverage here

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.